BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11177301)

  • 1. The function of endogenous protective systems in patients with insulin-dependent diabetes mellitus and polyneuropathy: effect of antioxidant therapy.
    Strokov IA; Manukhina EB; Bakhtina LY; Malyshev IY; Zoloev GK; Kazikhanova SI; Ametov AS
    Bull Exp Biol Med; 2000 Oct; 130(10):986-90. PubMed ID: 11177301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
    Tankova T; Koev D; Dakovska L
    Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy.
    Haak ES; Usadel KH; Kohleisen M; Yilmaz A; Kusterer K; Haak T
    Microvasc Res; 1999 Jul; 58(1):28-34. PubMed ID: 10388600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of alpha-lipoic acid on symptoms and skin blood flow in diabetic neuropathy.
    Jin HY; Joung SJ; Park JH; Baek HS; Park TS
    Diabet Med; 2007 Sep; 24(9):1034-8. PubMed ID: 17490418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy.
    Negrişanu G; Roşu M; Bolte B; Lefter D; Dabelea D
    Rom J Intern Med; 1999; 37(3):297-306. PubMed ID: 15532308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of diabetic polyneuropathy with alpha-lipoic acid is evidence based.
    Vereşiu IA
    Rom J Intern Med; 2004; 42(2):293-9. PubMed ID: 15529620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
    Hahm JR; Kim BJ; Kim KW
    J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetic polyneuropathy. Sequential therapy with alpha-lipoic acid passes the general practice test].
    Hedding-Eckerich M; Eckert MW
    MMW Fortschr Med; 2000 Sep; 142(36):38. PubMed ID: 11021068
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy.
    Androne L; Gavan NA; Veresiu IA; Orasan R
    In Vivo; 2000; 14(2):327-30. PubMed ID: 10836205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy].
    Gu XM; Zhang SS; Wu JC; Tang ZY; Lu ZQ; Li H; Liu C; Chen L; Ning G
    Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(35):2473-6. PubMed ID: 21092474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment for diabetic mononeuropathy with alpha-lipoic acid.
    Tankova T; Cherninkova S; Koev D
    Int J Clin Pract; 2005 Jun; 59(6):645-50. PubMed ID: 15924591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
    Ziegler D; Reljanovic M; Mehnert H; Gries FA
    Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictors of alpha-lipoic acid treatment efficacy in diabetic polyneuropathy of the lower limbs].
    Bregovskiĭ VB; Posokhina OV; Karpova IA
    Ter Arkh; 2005; 77(10):15-9. PubMed ID: 16320678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in type 2 diabetes: effect of antioxidants.
    Sena CM; Nunes E; Louro T; Proença T; Seiça RM
    Rev Port Cardiol; 2007 Jun; 26(6):609-19. PubMed ID: 17849945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.
    Koçak G; Aktan F; Canbolat O; Ozoğul C; Elbeğ S; Yildizoglu-Ari N; Karasu C;
    Diabetes Nutr Metab; 2000 Dec; 13(6):308-18. PubMed ID: 11232755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of thiolepta in diabetic polyneuropathy: results of the study ETIKA].
    Strokov IA; Fokina AS; Golovacheva VA; Kochetov AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5):36-41. PubMed ID: 23739501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of treatment of diabetic rats with combinations of pycnogenol, beta-carotene, and alpha-lipoic acid on parameters of oxidative stress.
    Berryman AM; Maritim AC; Sanders RA; Watkins JB
    J Biochem Mol Toxicol; 2004; 18(6):345-52. PubMed ID: 15674846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic neuropathy--choices of treatment.
    Bruckner I; Bustan C; Adamescu E; Dobjanschi C
    Rom J Intern Med; 2002; 40(1-4):53-60. PubMed ID: 15526540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-lipoic acid treatment prevents the diabetes-induced attenuation of the afferent limb of the baroreceptor reflex in rats.
    Gouty S; Regalia J; Cai F; Helke CJ
    Auton Neurosci; 2003 Oct; 108(1-2):32-44. PubMed ID: 14614962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of heat shock proteins may combat insulin resistance.
    McCarty MF
    Med Hypotheses; 2006; 66(3):527-34. PubMed ID: 16309849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.